{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:29:00Z","timestamp":1769880540205,"version":"3.49.0"},"reference-count":45,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2020.5021","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T07:25:30Z","timestamp":1584689130000},"source":"Crossref","is-referenced-by-count":6,"title":["Simultaneous inhibition of atypical protein kinase\u2011C and mTOR impedes bladder cancer cell progression"],"prefix":"10.3892","author":[{"given":"Rekha","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SM Anisul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Bommareddy","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracess","family":"Smalley","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildred","family":"Acevedo\u2011Duncan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"key20200713190407_b1-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"key20200713190407_b2-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.eururo.2016.03.011","article-title":"Pathology and genetics: Tumours of the urinary system and male genital system: Clinical implications of the 4th edition of the WHO classification and beyond","volume":"70","author":"Montironi","year":"2016","journal-title":"Eur Urol"},{"key":"key20200713190407_b3-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1158\/1078-0432.CCR-05-1505","article-title":"Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder","volume":"12","author":"Abraham","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20200713190407_b4-ijo-56-06-1373","first-page":"524","article-title":"Pathology of bladder cancer: Assessment of prognostic variables and response to therapy","volume":"17","author":"Reuter","year":"1990","journal-title":"Semin Oncol"},{"key":"key20200713190407_b5-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"key20200713190407_b6-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0302-2838(02)00060-X","article-title":"Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy","volume":"41","author":"Gschwend","year":"2002","journal-title":"Eur Urol"},{"key":"key20200713190407_b7-ijo-56-06-1373","first-page":"1","volume-title":"Lehninger principles of biochemistry","author":"Nelson","year":"2008","edition":"5th ed"},{"key":"key20200713190407_b8-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.bbamcr.2018.02.002","article-title":"Protein Kinase C-\u03b6 stimulates colorectal cancer cell carcinogenesis via PKC-\u03b6\/Rac1\/Pak1\/\u03b2-Catenin signaling cascade","volume":"1865","author":"Islam","year":"2018","journal-title":"Biochim Biophys Acta Mol cell Res"},{"key":"key20200713190407_b9-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/19336918.2018.1546513","article-title":"The modulation of actin dynamics via atypical Protein Kinase-C activated Cofilin regulates metastasis of colorectal cancer cells","volume":"13","author":"Islam","year":"2019","journal-title":"Cell Adh Migr"},{"key":"key20200713190407_b10-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"key20200713190407_b11-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phos-phoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713190407_b12-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol Cell"},{"key":"key20200713190407_b13-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"key20200713190407_b14-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/emboj.2008.120","article-title":"The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C","volume":"27","author":"Facchinetti","year":"2008","journal-title":"EMBO J"},{"key":"key20200713190407_b15-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/emboj.2008.119","article-title":"Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling","volume":"27","author":"Ikenoue","year":"2008","journal-title":"EMBO J"},{"key":"key20200713190407_b16-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"key20200713190407_b17-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"12519","DOI":"10.1073\/pnas.0505641102","article-title":"Atypical PKC contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer","volume":"102","author":"Eder","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"key20200713190407_b18-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1189\/jlb.0708429","article-title":"Pivotal Advance: PKC is required for migration of macrophages","volume":"85","author":"Guo","year":"2009","journal-title":"J Leukoc Biol"},{"key":"key20200713190407_b19-ijo-56-06-1373","first-page":"1537","article-title":"Analysis of PKC-\u03b6 protein levels in normal and malignant breast tissue subtypes","volume":"17","author":"Smalley","year":"2019","journal-title":"Oncol Lett"},{"key":"key20200713190407_b20-ijo-56-06-1373","article-title":"Abstract 719: Combination of atypical protein kinase-C inhibitor and 5-fluo-rouracil retards the proliferation of colorectal cancer cells","volume":"719","author":"Islam","year":"2019","journal-title":"Mol Cell Biol"},{"key":"key20200713190407_b21-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"key20200713190407_b22-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"key20200713190407_b23-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2184.2007.00506.x","article-title":"Involvement of PKC-\u03b9 in glioma proliferation","volume":"41","author":"Patel","year":"2008","journal-title":"Cell Prolif"},{"key":"key20200713190407_b24-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1101\/gad.1256504","article-title":"Living with or without cyclins and cyclin-dependent kinases","volume":"18","author":"Sherr","year":"2004","journal-title":"Genes Dev"},{"key":"key20200713190407_b25-ijo-56-06-1373","volume-title":"The protein kinase factsbook","author":"Hardie","year":"1995"},{"key":"key20200713190407_b26-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.21873\/anticanres.11091","article-title":"Expression of the p53 inhibitors mdm2 and mdm4 as outcome predictor in muscle-invasive bladder cancer","volume":"36","author":"Kriegmair","year":"2016","journal-title":"Anticancer Res"},{"key":"key20200713190407_b27-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"15678","DOI":"10.1038\/s41598-017-15901-9","article-title":"Loss of lamin B1 is a biomarker to quantify cellular senescence in photoaged skin","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"key20200713190407_b28-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.2204114","article-title":"Replicative senescence: The human fibroblast comes of age","volume":"249","author":"Goldstein","year":"1990","journal-title":"Science"},{"key":"key20200713190407_b29-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev.cellbio.19.011102.111135","article-title":"Cadherins as Modulators of Cellular Phenotype","volume":"19","author":"Wheelock","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"key20200713190407_b30-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"43124","DOI":"10.18632\/oncotarget.8988","article-title":"Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers","volume":"7","author":"De","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713190407_b31-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1006\/excr.1999.4639","article-title":"SHC-\u03b15\u03b21 integrin interactions regulate breast cancer cell adhesion and motility","volume":"252","author":"Mauro","year":"1999","journal-title":"Exp Cell Res"},{"key":"key20200713190407_b32-ijo-56-06-1373","first-page":"1135","article-title":"Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential","volume":"6","author":"Jackson","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20200713190407_b33-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1756-9966-28-152","article-title":"The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: An immunohistochemical study on tissue micro-array","volume":"28","author":"Xiao","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"key20200713190407_b34-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbacli.2015.11.003","article-title":"The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials","volume":"5","author":"Malley","year":"2016","journal-title":"BBA Clin"},{"key":"key20200713190407_b35-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/labinvest.2010.133","article-title":"Expanding therapeutic targets in bladder cancer: The PI3K\/Akt\/mTOR pathway","volume":"90","author":"Ching","year":"2010","journal-title":"Lab Invest"},{"key":"key20200713190407_b36-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ctrv.2014.11.003","article-title":"Emerging therapeutic targets in bladder cancer","volume":"41","author":"Carneiro","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"key20200713190407_b37-ijo-56-06-1373","first-page":"1836","article-title":"Inhibition of atypical protein kinase C-\u03b9 effectively reduces the malignancy of prostate cancer cells by downregulating the NF-\u03baB signaling cascade","volume":"53","author":"Apostolatos","year":"2018","journal-title":"Int J Oncol"},{"key":"key20200713190407_b38-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3892\/ijo.2017.4131","article-title":"Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis","volume":"51","author":"Ratnayake","year":"2017","journal-title":"Int J Oncol"},{"key":"key20200713190407_b39-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"11541","DOI":"10.1007\/s13277-016-5083-1","article-title":"mTOR inhibitors in urinary bladder cancer","volume":"37","author":"Pinto-Leite","year":"2016","journal-title":"Tumor Biol"},{"key":"key20200713190407_b40-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/jcp.25443","article-title":"Combination of rapamycin and resveratrol for treatment of bladder cancer","volume":"232","author":"Alayev","year":"2017","journal-title":"J Cell Physiol"},{"key":"key20200713190407_b41-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jcb.24997","article-title":"The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells","volume":"116","author":"Alayev","year":"2015","journal-title":"J Cell Biochem"},{"key":"key20200713190407_b42-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"109665","DOI":"10.1016\/j.biopha.2019.109665","article-title":"Atypical Protein Kinase-C inhibitors exhibit a synergistic effect in facilitating DNA damaging effect of 5-fluorouracil in colorectal cancer cells","volume":"120","author":"Islam","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"key20200713190407_b43-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature06955","article-title":"Global control of cell-cycle transcription by coupled CDK and network oscillators","volume":"453","author":"Orlando","year":"2008","journal-title":"Nature"},{"key":"key20200713190407_b44-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/pr900392b","article-title":"Different changes in protein and phosphoprotein levels result from serum starvation of high-grade glioma and adenocarcinoma cell lines","volume":"9","author":"Levin","year":"2010","journal-title":"J Proteome Res"},{"key":"key20200713190407_b45-ijo-56-06-1373","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","article-title":"Rapamycin and mTOR kinase inhibitors","volume":"1","author":"Ballou","year":"2008","journal-title":"J Chem Biol"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:08:29Z","timestamp":1594667309000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2020.5021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3892\/ijo.2020.5021","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}